SPX Technologies

The latest read

Computed from the data on Oct 23, 2026. Every figure links back to its source in the sections below.

• Revenue over the four quarters to June 27, 2026: $2.48 billion, up 21% from a year earlier.SEC EDGAR filings (XBRL)
• Free cash flow (operating cash flow minus capital expenditure) over the four quarters to June 27, 2026: $0.30 billion, up 36% from a year earlier.SEC EDGAR filings (XBRL)
• Capital expenditure over the four quarters to June 27, 2026: $0.12 billion, up 300% from a year earlier.SEC EDGAR filings (XBRL)
• Long-term debt issued in the fiscal year to December 31, 2025: $1.26 billion.SEC EDGAR filings (10-K)
• Latest earnings call or results release (July 30, 2026): sentiment 0.70 on a −1 to +1 scale (confident, opportunity-framed), confidence 0.85 of 1.Palanor Discourse
• Guidance in the last 90 days: 9 outlook figures raised, 0 lowered, 0 held.Guidance Ledger (8-K results releases)
• Latest annual report (filed February 25, 2026): 3 risk factors added, 0 removed.Risk Factor Changes (10-K Item 1A)
• Insiders were net sellers in Q1 2026: $9.3 million on the open market.SEC Form 4
• 512 institutional managers reported a position at June 30, 2026 (+31 on the quarter before).SEC Form 13F
• H-1B filings certified in Q2 2026: 2 (5 a year earlier).U.S. Department of Labor (OFLC)

Company Posture covers S&P 500 companies.

No bond term sheets or tagged debt on file for SPX Technologies yet.

0 actions in the last 12 months · 0 workers in WARN notices · latest Apr 15, 2009

1. Apr 15, 2009SEC filing
   8-K Item 2.05 (exit or disposal costs)

WARN notices cover layoffs above the federal size thresholds in the states Palanor reads; they are not every layoff. A WARN notice filed near an 8-K Item 2.05 of SPX Technologies is linked to it and counted once. Methodology and coverage

SPX Technologies's rows in Palanor's event trackers over the last three years, its own and its subsidiaries': FDA decisions, deal filings, IPO filings, private raises, insider clusters and 13D stakes, and distress filings. Each links to its filing or FDA record.

Records as filed. An FDA date is the agency's goal date; a filing records a step or an event, not what follows. Nothing here is a forecast or advice.

Charts

Live charts: each one redraws from today’s data and has an image link to paste into a document or slide.

Filings and records

The last two years of notable 8-Ks, offerings, annual reports, federal awards, lobbying reports, patents and other public records, newest first.

1. Jul 27, 20268-K
   Director or officer changeItem 5.02
2. Jun 22, 20268-K
   Director or officer changeItem 5.02
3. May 12, 20268-K
   Shareholder vote resultsItem 5.07
4. Mar 10, 2026Patent
   Patent granted: ROBOTIC ARM COOPERATING WITH AN OFF-ROAD CAPABLE BASE VEHICLEUS 12569987
5. Feb 25, 202610-K
   Annual report (10-K)3 risk factors added, 0 removed
6. Feb 24, 2026Patent
   Patent granted: AIR-MIXING PLENUM AND METHOD OF MIXING FLOWS OF AIR THEREWITHUS 12560340
7. Feb 2, 20268-K
   Director or officer changeItem 5.02
8. Jan 20, 2026Patent
   Patent granted: AUTONOMOUS COLLABORATIVE ROBOTIC SYSTEM AND METHODUS 12528210
9. Jan 13, 2026Patent
   Patent granted: Variable Orifice Restriction DeviceUS 12523374
10. Dec 9, 2025Patent
    Patent granted: MODULAR PLATFORM ELECTRIC TRENCH HEATERUS 12495469
11. Sep 11, 20258-K
    Material agreement signedItem 1.01
12. May 13, 20258-K
    Shareholder vote resultsItem 5.07
13. Feb 26, 202510-K
    Annual report (10-K)0 risk factors added, 0 removed
14. Feb 23, 202410-K
    Annual report (10-K)5 risk factors added, 2 removed

Peers

Companies in the same sector in the S&P 500, Russell 1000 or MidCap 400, closest in revenue first. Trailing twelve months, from SEC filings.

Identity

SEC CIK

88205

LEI

P761FCI0CPOG24I8JE10

Wikidata

Q2207629